Articles

Advice from a ‘nervous and jumpy’ Wall Street bull as second half gets under way

RBC Capital’s Lori Calvasina joins other Wall Street banks in lifting her S&P 500 target, but says she’s plenty jittering about where markets go from here.

Roaring Kitty cements Chewy’s meme-stock status, despite company’s improving fundamentals

Influential trader Keith Gill, also known as Roaring Kitty, has taken a 6.6% stake in Chewy, thrusting the online pet-products retailer into the meme-stock spotlight.

10-year yields have ‘little to no’ downside — which means stocks can’t climb much from here, strategist says

Yields on the benchmark 10-year Treasury have little room to fall, which will cap valuations on U.S. equities from already elevated valuations, says a market strategist.

Barry Diller joins the battle for control of Paramount after talks with Skydance are scrapped: Report

Paramount Global’s stock rose 3.1% early Tuesday, after a report that billionaire Barry Diller’s IAC is exploring a bid for Paramount, after talks between the parent of CBS and Nickelodeon and David Ellison’s Skydance Media fell apart in June.

Tesla’s stock set to snap win streak as investors brace for deliveries data

Tesla’s stock was headed lower on Tuesday for the first time in over a week, as investors expressed some concern over what the electric-vehicle giant will say about second-quarter deliveries.

Siemens Energy to hire 10,000 new staff in $1.3 billion push to boost grid unit

Siemens Energy is planning expand its manufacturing capacity worldwide in order to meet growing demand for electricity infrastructure equipment

Why CrowdStrike’s stock just got downgraded after a monster rally

CrowdStrike’s enterprise-value-to-sales ratio is the highest among large software stocks that Piper Sandler tracks.

Alibaba is buying back more and more stock as prices extend selloff

Alibaba disclosed Tuesday that it continued to increase stock repurchases as prices struggled to gain traction.

Moderna gets U.S. government funding for bird-flu vaccine development

Moderna Inc.’s efforts to develop a bird-flu vaccine are getting a $176 million boost from the U.S. government, the company said Tuesday.

The S&P 500’s reliance on a few winning stocks is getting worse

S&P 500’s performance in the second quarter would be negative without these 10 stocks

Tesla stock shows a curious pattern before and after earnings that you can trade

Shares typically decline during the two weeks ahead of earnings and gain over the following two weeks.

Where to invest if the Fed can’t get inflation down to 2%

Investing for retirement, college and other longer-term goals should favor stocks over bonds.
1 1,003 1,004 1,005 1,006 1,007 2,306